Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - If each potential infringer has been given a ballpark figure for a license,

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

milestone

Rank: President [?]

Points: 18650 [?]

Votes: 158 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

If each potential infringer has been given a ballpark figure for a license,

posted on Jan 15, 2009 12:28PM

how many would prefer to settle before re-examination is completed?

The reason I ask is linked to Intel's 90% drop in profits for Q4. Settlement subsequent to revalidation will obviously be at a higher license fee, and consequently a greater percentage of any profits.

How does the FD of a Company put on notice balance current licensees, USPTO arguments and the reverse-engineered evidence of potential infringement against the possible outcome of the USPTO decision while fulfilling their fiduciary duty?

Be well

1 Recommendations

Re: If each potential infringer has been given a ballpark figure for a license,

gcduck

Jan 15, 2009 12:47PM